Treating Drivers of Suicide in Primary Care using Jaspr Health
使用 Jaspr Health 在初级保健中治疗自杀驱动者
基本信息
- 批准号:10383171
- 负责人:
- 金额:$ 39.8万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-09-10 至 2022-08-31
- 项目状态:已结题
- 来源:
- 关键词:Accident and Emergency departmentAcuteAddressAdministratorAdoptionAdultAgeAgitationAmericanBehavioralCaringCause of DeathCessation of lifeClinicCompanionsCompetenceContractsCounselingDevelopmentDistressEffectivenessEmergency Department patientEnsureEvaluationEvidence based interventionEvidence based practiceFeeling suicidalHealthHealth PersonnelHealthcareHealthcare SystemsHomeHuman ResourcesIndividualMental Health ServicesMethodsMovementOccupationsOutpatientsPainParticipantPatient RecruitmentsPatientsPersonsPhasePrevention strategyPrimary Health CareProceduresProcessPublic HealthRandomized Controlled TrialsRecoveryReportingResearch MethodologyResourcesRisk AssessmentRunningSelf EfficacySuicideSuicide attemptSuicide preventionTechnologyTestingTimeTreatment EffectivenessUnited StatesVisitactive controlalcohol misusealcohol use disorderbasebehavioral healthbrief interventioncare providersclinically relevantcomorbiditycopingdesigndigitalemotional distressevidence baseexperienceflexibilityformative assessmentfunctional improvementhealth goalsimprovediterative designpreventive interventionprototypepublic health relevancereducing suicidesatisfactionscreeningskillssmartphone Applicationsuicidalsuicidal behaviorsuicidal patientsuicidal risktooltrial comparinguser centered design
项目摘要
PROJECT SUMMARY/ABSTRACT
Suicide remains a serious public health problem in the U.S. as rates have risen nearly each year since
2005, from 11.0 per 100,000 to 14.8 per 100,000 in 2018, totaling 48,344 in 2018; 1.4 million U.S. adults made
a suicide attempt, and another 12 million thought seriously about killing themselves that same year. Alcohol
use disorder (AUD) exponentially increases suicide risk and can also interfere with suicide prevention
intervention efforts. Suicide prevention initiatives over the past decade have targeted healthcare systems
(HCS) in general and primary care clinics (PCC) in particular because so many who die by suicide access their
primary care provider (PCP) in the months and year prior to their death. Though universal suicide screening is
now routinely conducted in PCC, many HCS and PCC struggle to provide suicide prevention evidence-based
practices (EBP) on par with other behavioral health EBP commonly treated in PCC. Digital technologies can
efficiently and reliably help deliver suicide prevention EBP in PCC and increase the confidence and
competence of PCP in treating suicide, including AUD that may interfere with these efforts.
Jaspr Health (“Jaspr”; R44MH108222) is a suicide prevention platform originally designed for use by
acutely suicidal patients in emergency departments (ED) to deliver suicide prevention EBP. Grounded in
Jobes’ Collaborative Assessment and Management of Suicidality (CAMS), Jaspr guides patients in completing
a comprehensive suicide risk assessment and lethal means counseling, builds a crisis stabilization plan, and
teaches behavioral skills to reduce imminent distress; videos of people with live experience (PLE) offer wisdom
and hope for getting through suicide crises. Information is summarized for the care team to aid in discharge
disposition planning. A companion app provides support post-discharge. Results from a randomized controlled
trial (RCT; N=31) comparing Jaspr to Care-as-Usual strongly support its feasibility, acceptability, and
effectiveness in increasing delivery of EBP, reducing agitation and distress, improving capacity to cope with
suicidal thoughts, and improving ED satisfaction.
This 34-month fast track seeks to increase the public health impact of Jaspr Health by extending its utility
to deliver evidence-based brief interventions that directly target and treat a person’s reasons for wanting to die
(their “drivers” for suicide) while simultaneously addressing alcohol misuse. The proposal is defined by three
project stages which include: (1) a proof-of-concept formative evaluation stage where we will iteratively
design, test, and build a prototype (Phase I; Months 1-10); (2) a product design-and-build formative
evaluation stage, where we will design, build and test all remaining features and apps (Phase II; Months 11-
22); and (3) a summative evaluation stage involving a pilot test (N=20) and a RCT (N=120) comparing Jaspr
to a suicide prevention app and other online wellness resources (Phase II; Months 23-34).
项目总结/摘要
自杀在美国仍然是一个严重的公共卫生问题,自那以来,自杀率几乎每年都在上升。
2005年,从每10万人11.0人增加到2018年的每10万人14.8人,2018年总计48,344人; 140万美国成年人
自杀未遂,另有1200万人在同一年认真考虑过自杀。醇
使用障碍(AUD)呈指数级增加自杀风险,也可能干扰自杀预防
干预努力。在过去的十年里,自杀预防计划针对的是医疗保健系统。
(HCS)特别是在普通诊所和初级保健诊所(PCC),因为许多死于自杀的人都能获得他们的
初级保健提供者(PCP)在他们死亡前的几个月和一年。虽然普遍的自杀筛查是
现在在PCC中常规进行,许多HCS和PCC努力提供基于证据的自杀预防
实践(EBP)与PCC中通常治疗的其他行为健康EBP相同。数字技术可以
有效和可靠地帮助在PCC中提供自杀预防EBP,并增加信心,
PCP治疗自杀的能力,包括可能干扰这些努力的AUD。
Jaspr Health(“Jaspr”; R44 MH 108222)是一个自杀预防平台,最初设计用于
急性自杀患者在急诊科(艾德)提供自杀预防EBP。立足于
Jobes的合作评估和自杀管理(CAMS),Jaspr指导患者完成
全面的自杀风险评估和致命手段咨询,建立危机稳定计划,
教授行为技能,以减少迫在眉睫的痛苦;视频的人与生活经验(PLE)提供智慧
希望能度过自杀危机总结信息,以便护理团队协助出院
处置规划配套应用程序提供出院后支持。来自随机对照的结果
一项比较Jaspr与Care-as-Monthal的试验(RCT; N=31)强烈支持其可行性、可接受性和
有效地增加EBP的输送,减少躁动和痛苦,提高科普能力,
自杀念头,并提高艾德满意度。
这个为期34个月的快速通道旨在通过扩展Jaspr Health的实用性来增加其对公共卫生的影响
提供基于证据的简短干预措施,直接针对和治疗一个人想死的原因,
(他们的自杀“司机”),同时解决酒精滥用问题。该提案定义为三个
项目阶段包括:(1)概念验证形成性评估阶段,我们将迭代
设计、测试和构建原型(第一阶段; 1-10个月);(2)产品设计和构建形成
评估阶段,我们将设计,构建和测试所有剩余的功能和应用程序(第二阶段; 11个月-
(3)总结性评价阶段,包括初步试验(N=20)和RCT(N=120),比较Jaspr
自杀预防应用程序和其他在线健康资源(第二阶段; 23-34个月)。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Linda A Dimeff其他文献
Linda A Dimeff的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Linda A Dimeff', 18)}}的其他基金
iKinnect Mobile Technology to Reduce Teen Substance Misuse and Health Disparities
iKinnect 移动技术可减少青少年药物滥用和健康差异
- 批准号:
10545162 - 财政年份:2023
- 资助金额:
$ 39.8万 - 项目类别:
Treating Drivers of Suicide in Primary Care using Jaspr Health TABA Supplement
使用 Jaspr Health TABA 补充剂治疗初级保健中的自杀驱动者
- 批准号:
10805635 - 财政年份:2023
- 资助金额:
$ 39.8万 - 项目类别:
Treating Drivers of Suicide in Primary Care using Jaspr Health
使用 Jaspr Health 在初级保健中治疗自杀驱动者
- 批准号:
10689325 - 财政年份:2021
- 资助金额:
$ 39.8万 - 项目类别:
iKinnect2.0 for Juvenile Justice Involved Youth at Risk for Suicide Diversity Supplement
iKinnect2.0 涉及青少年司法 自杀风险青少年多样性补充
- 批准号:
10815920 - 财政年份:2021
- 资助金额:
$ 39.8万 - 项目类别:
iKinnect2.0 for Juvenile Justice Involved Youth at Risk for Suicide
iKinnect2.0 青少年司法涉及有自杀风险的青少年
- 批准号:
10625446 - 财政年份:2021
- 资助金额:
$ 39.8万 - 项目类别:
Treating Drivers of Suicide in Primary Care using Jaspr Health
使用 Jaspr Health 在初级保健中治疗自杀驱动者
- 批准号:
10659264 - 财政年份:2021
- 资助金额:
$ 39.8万 - 项目类别:
iKinnect2.0 for Juvenile Justice Involved Youth at Risk for Suicide
iKinnect2.0 青少年司法涉及有自杀风险的青少年
- 批准号:
10255880 - 财政年份:2021
- 资助金额:
$ 39.8万 - 项目类别:
CAMS Relational Agent System (CAMS-RAS) for Suicide Prevention
用于预防自杀的 CAMS 关系代理系统 (CAMS-RAS)
- 批准号:
9978152 - 财政年份:2015
- 资助金额:
$ 39.8万 - 项目类别:
Using Mobile Technology to Enhance MST Outcomes
使用移动技术增强 MST 成果
- 批准号:
8313372 - 财政年份:2013
- 资助金额:
$ 39.8万 - 项目类别:
PracticeGround: Transforming Training and Delivery of Mental Health EBPs
PracticeGround:转变心理健康 EBP 的培训和实施
- 批准号:
8834653 - 财政年份:2011
- 资助金额:
$ 39.8万 - 项目类别:
相似海外基金
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 39.8万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 39.8万 - 项目类别:
Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 39.8万 - 项目类别:
Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 39.8万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 39.8万 - 项目类别:
Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 39.8万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 39.8万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 39.8万 - 项目类别:
Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 39.8万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
- 批准号:
484000 - 财政年份:2023
- 资助金额:
$ 39.8万 - 项目类别:
Operating Grants